Gastroparesis Management Market: By Drug, By Type, By Distribution Channel, By Route of Administration, and Geography    

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Gastroparesis Management Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug (Metoclopramide, Erythromycin, Domperidone, Others), By Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Intravenous, Nasal, Oral, Others), and Region    

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Gastroparesis Management Market size was valued at US$ 4,348.61 million in 2023 and is poised to grow at a CAGR of 4.6% from 2024 to 2030. Gastroparesis is also called delayed gastric emptying, is a disorder of the stomach that hinders the movement of food from the stomach to the small intestine. Generally, muscles of the GI tract are controlled by the vagus nerve, which contracts to move the food contents throughout the GI tract. Gastroparesis occurs when the vagus nerve is damaged by illness or injury which leads to slower movement of food contents from the stomach to the small intestine. The majority of people with gastroparesis have idiopathic gastroparesis of which the cause is unknown. Diabetes is commonly known as the cause of gastroparesis. Elevated sugar levels in diabetics are believed to cause damage to the vagus nerve and other causes of gastroparesis include gastric surgery, Parkinson's disease, and multiple sclerosis. Gastroparesis is generally found in females than males.

The gastroparesis management market report evaluates all-inclusive data that enriches the scope, understanding, and application of this report. Gastroparesis is a condition that primarily affects diabetics with type 1 and type 2 diabetes. The stomach takes an abnormally long time to empty its contents in this condition. Gastroparesis is treated with drugs such as erythromycin, antiemetics, and Reglan. Furthermore, due to the increased prevalence of type 1 and type 2 diabetes, which may increase the risk of gastroparesis, there are 119 completed and continuing clinical trials for gastroparesis medicines. This increases the demand for these drugs and, to some extent, fuels the total market. However, the market may be hampered by adverse effects associated with gastroparesis medications.

summary download arrow Download Free Sample

Global Gastroparesis Management Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.6%

Largest Market

North America

Fastest Growing Market

North America

Gastroparesis Management Market Dynamics

Rising prevalence of diabetes and gastroparesis, increasing gastroparesis awareness among healthcare professionals expected to propel market for gastroparesis management market over the forecast period. Moreover, rising clinical development candidates for treating gastroparesis is expected to fuel the market revenue for gastroparesis management market. For instance, as of now, there are around six drug candidates in clinical development which act by different mechanisms and route of administration. However, a dearth of specific treatment options, large medical unmet need, and lack of gastroparesis management guidelines expected to hamper the Gastroparesis Management Market over the forecast period.

Global Gastroparesis Management Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 4,348.61 million

Market CAGR

4.6%

By Drug

  • Metoclopramide,
  • Erythromycin,
  • Domperidone,
  • Others

By Type

  • Diabetic Gastroparesis,
  • Idiopathic Gastroparesis,
  • Post-surgical Gastroparesis,
  • Others

By Distribution Channel

  • Hospital Pharmacies,
  • Retail Pharmacies,
  • Online Pharmacies

By Route of Administration

  • Intravenous,
  • Nasal,
  • Oral,
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The gastroparesis management market size was valued at US$ 4,348.61 million in 2023

Abbott Laboratories, Boston Scientific Corporation, C. R. Bard, Inc, Evoke Pharma, Salix Pharmaceuticals, Inc, Janssen Global Services, LLC, Medtronic,

North America is the fastest-growing region for gastroparesis Mmanagement market .

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Gastroparesis Management Market Introduction 
2.1.Global Gastroparesis Management Market  - Taxonomy
2.2.Global Gastroparesis Management Market  - Definitions
2.2.1.Drug
2.2.2.Type
2.2.3.Distribution Channel
2.2.4.Route of Administration
2.2.5.Region
3. Global Gastroparesis Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Gastroparesis Management Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Gastroparesis Management Market  By Drug, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Metoclopramide,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Erythromycin,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Domperidone,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Gastroparesis Management Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Diabetic Gastroparesis,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Idiopathic Gastroparesis,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Post-surgical Gastroparesis,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Gastroparesis Management Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Gastroparesis Management Market  By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Intravenous,
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Nasal,
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Oral,
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Gastroparesis Management Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Gastroparesis Management Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Metoclopramide,
10.1.2.Erythromycin,
10.1.3.Domperidone,
10.1.4.Others
10.2.  Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Diabetic Gastroparesis,
10.2.2.Idiopathic Gastroparesis,
10.2.3.Post-surgical Gastroparesis,
10.2.4.Others
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies,
10.3.2.Retail Pharmacies,
10.3.3.Online Pharmacies
10.4.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Intravenous,
10.4.2.Nasal,
10.4.3.Oral,
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Gastroparesis Management Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Metoclopramide,
11.1.2.Erythromycin,
11.1.3.Domperidone,
11.1.4.Others
11.2.  Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Diabetic Gastroparesis,
11.2.2.Idiopathic Gastroparesis,
11.2.3.Post-surgical Gastroparesis,
11.2.4.Others
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies,
11.3.2.Retail Pharmacies,
11.3.3.Online Pharmacies
11.4.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Intravenous,
11.4.2.Nasal,
11.4.3.Oral,
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Gastroparesis Management Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Metoclopramide,
12.1.2.Erythromycin,
12.1.3.Domperidone,
12.1.4.Others
12.2.  Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Diabetic Gastroparesis,
12.2.2.Idiopathic Gastroparesis,
12.2.3.Post-surgical Gastroparesis,
12.2.4.Others
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies,
12.3.2.Retail Pharmacies,
12.3.3.Online Pharmacies
12.4.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Intravenous,
12.4.2.Nasal,
12.4.3.Oral,
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Gastroparesis Management Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Metoclopramide,
13.1.2.Erythromycin,
13.1.3.Domperidone,
13.1.4.Others
13.2.  Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Diabetic Gastroparesis,
13.2.2.Idiopathic Gastroparesis,
13.2.3.Post-surgical Gastroparesis,
13.2.4.Others
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies,
13.3.2.Retail Pharmacies,
13.3.3.Online Pharmacies
13.4.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Intravenous,
13.4.2.Nasal,
13.4.3.Oral,
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Gastroparesis Management Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Metoclopramide,
14.1.2.Erythromycin,
14.1.3.Domperidone,
14.1.4.Others
14.2.  Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Diabetic Gastroparesis,
14.2.2.Idiopathic Gastroparesis,
14.2.3.Post-surgical Gastroparesis,
14.2.4.Others
14.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospital Pharmacies,
14.3.2.Retail Pharmacies,
14.3.3.Online Pharmacies
14.4.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Intravenous,
14.4.2.Nasal,
14.4.3.Oral,
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Evoke Pharma
15.2.2.Neurogastrx
15.2.3.Takeda Pharmaceutical
15.2.4.Pfizer
15.2.5.Atlantic Healthcare
15.2.6.Salix Pharmaceuticals, Inc.
15.2.7.ANI Pharmaceuticals
15.2.8.Processa Pharmaceuticals, Inc.
15.2.9.Vanda Pharmaceuticals Inc
15.2.10.CinDome Pharma, Inc.Oracle Corporation
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Evoke Pharma
  • Neurogastrx
  • Takeda Pharmaceutical
  • Pfizer
  • Atlantic Healthcare
  • Salix Pharmaceuticals, Inc.
  • ANI Pharmaceuticals
  • Processa Pharmaceuticals, Inc.
  • Vanda Pharmaceuticals Inc
  • CinDome Pharma, Inc.Oracle Corporation

Related Industry Reports

Gastrointestinal Molecular Diagnostics Market

Post Surgical Compression Garments Market

Gastroenterology Devices Market

Gastrointestinal Therapeutics Market